中文
| Catalogue |
| Recommend Products |
Company News
- The Key Role and Application Advances of IFN-γ Detection in CAR-T Cell Therapy Development... 11/30/2025
- FMC63 scFv: The Core Component of CD19-Targeted CAR-T Therapy and the Application Advances... 11/29/2025
- Glycosylated Antibodies: How to Reveal Novel Diagnostic and Therapeutic Targets for Hepato... 11/26/2025
- How to Achieve Precise Selection of IHC Antibodies in Cancer Biomarker Detection? 11/25/2025
- Can FGFR2b Antibody Become a New Option for Targeted Therapy in Gastric Cancer? 11/24/2025
- How Do IGJ Antibodies Unravel the Mysteries of Immunoglobulin Structure and Function? 11/23/2025
- How Do Phosphorylated Tau Antibodies Reveal the Mechanism of Protective Mutations in Alzhe... 11/22/2025
- Can Factor XIIIa Antibody Reveal New Dimensions in Hemophilia Diagnosis and Treatment? 11/21/2025
- Can CDK2 Inhibitors Overcome the Challenge of Drug Resistance in Cancer Therapy? 11/21/2025
- Can c-Met Antibodies Become a New Hope for Tumor Targeted Therapy? 11/20/2025
- How Do c-Myc Antibodies Reveal New Mechanisms of Protein Interaction Regulating Gene Expre... 11/19/2025
- How Can Immunohistochemistry Kits Enhance Experimental Efficiency and Result Reliability? 11/18/2025
- Insight into the "Signal Amplifier" of Life Activities: Exploring the Principle of the AMP... 11/17/2025
- Can CD366 Become the Next Key Target in Cancer Immunotherapy? 11/14/2025
- CTLA-4 Antibodies: How to Achieve a Breakthrough in Balancing Efficacy and Safety? 11/11/2025
- How to Achieve Precise Selection of IHC Antibodies in Cancer Biomarker Detection? 11/7/2025
- How Does the IFN-γ Detection Kit Ensure Quality Control of Cell Preparations? 11/6/2025
- Is There an Inevitable Link Between PD-1 Antibody Half-Life and Clinical Efficacy? 11/5/2025
- A Guide to Anti-Idiotypic Antibodies: From Definition, Classification to Customized Soluti... 11/4/2025
- Plasma p-tau231 Antibodies: Can They Become a New Tool for Early Pathological Detection of... 11/3/2025